Balimbingan, Alsamer S.

HRN: 28-90-40  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/24/2026
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
04/24/2026
05/01/2026
IV
430mg
Q6
PCAP-C
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: